Transplantation of MSCs Overexpressing HGF into a Rat Model of Liver Fibrosis
- PMID: 26194009
- DOI: 10.1007/s11307-015-0869-x
Transplantation of MSCs Overexpressing HGF into a Rat Model of Liver Fibrosis
Abstract
Purpose: The aim of this study is to evaluate the effect of overexpressing human hepatocyte growth factor (HGF) for mesenchymal stem cells (MSCs) in liver fibrosis regeneration and magnetic resonance (MR) tracking of MSCs in rat liver.
Procedures: MSCs were transfected with ad-HGF/ad-green fluorescent protein (GFP) and labeled with superparamagnetic iron oxide (SPIO). The characteristics of SPIO-HGF/MSCs were investigated. Prussian blue staining for iron assessment was conducted in vitro and in vivo. SPIO-HGF/MSCs (group A) or SPIO-GFP/MSCs (group B) were transplanted into a rat model of liver fibrosis, and MR imaging of the rat liver was performed. The signal to noise ratio (SNR) and R2* (1/T2*) value were measured. Prussian blue staining was performed to detect the in vivo distribution of MSCs, and liver Ki67 immunohistochemistry (IHC) staining was studied. The serum levels of HGF, alanine aminotransferase (ALT) and hyaluronic acid (HA) were determined.
Results: The positive rate of HGF transfection was 93.17 % and the HGF/MSCs were labeled with SPIO successfully (97.80 ± 1.06 %). Labeling of MSCs with SPIO did not alter cell proliferation in vitro. The signal intensity of liver T2* WI images decreased on day 1 after cell transplantation and recovered to pre-transplantation level on day 15 (group A) and day 13 (group B). The SNR of group A were significantly lower than that of group B (P = 0.006), and the R2* values of group A were significantly higher than those of group B (P < 0.001). The R2* value had a significantly negative correlation with SNR. There were more Prussian blue-positive cells in of group A were more than in group B in vivo. The positive rate of Ki67 was 16.11 ± 2.13 %, and the serum level of ALT/HA was decreased in group A.
Conclusion: HGF transfection improved MSCs localization in the liver and aided liver repair. The R2* value might be a feasible index in addition to SNR to track the SPIO-MSC transplantation in the liver.
Keywords: Hepatocyte growth factor; Liver fibrosis; Magnetic resonance imaging; Mesenchymal stem cells; Superparamagnetic iron oxide.
Similar articles
-
Recent advances in the therapeutic efficacy of hepatocyte growth factor gene-modified mesenchymal stem cells in multiple disease settings.J Cell Mol Med. 2022 Sep;26(18):4745-4755. doi: 10.1111/jcmm.17497. Epub 2022 Aug 3. J Cell Mol Med. 2022. PMID: 35922965 Free PMC article. Review.
-
Effects of hepatocyte growth factor gene-transfected mesenchymal stem cells on dimethylnitrosamine-induced liver fibrosis in rats.Growth Factors. 2019 Aug;37(3-4):105-119. doi: 10.1080/08977194.2019.1652399. Epub 2019 Aug 27. Growth Factors. 2019. PMID: 31452434
-
MR tracking of SPIO-labeled mesenchymal stem cells in rats with liver fibrosis could not monitor the cells accurately.Contrast Media Mol Imaging. 2015 Nov-Dec;10(6):473-80. doi: 10.1002/cmmi.1650. Epub 2015 Jul 8. Contrast Media Mol Imaging. 2015. PMID: 26153152
-
In vivo magnetic resonance imaging of iron oxide-labeled, intravenous-injected mesenchymal stem cells in kidneys of rabbits with acute ischemic kidney injury: detection and monitoring at 1.5 T.Ren Fail. 2015;37(8):1363-9. doi: 10.3109/0886022x.2015.1073542. Epub 2015 Aug 7. Ren Fail. 2015. PMID: 26248484
-
Multimodal, rhodamine B isothiocyanate-incorporated, silica-coated magnetic nanoparticle–labeled human cord blood–derived mesenchymal stem cells for cell tracking.2009 Dec 11 [updated 2010 Jan 28]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2009 Dec 11 [updated 2010 Jan 28]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641578 Free Books & Documents. Review.
Cited by
-
Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented Review.J Clin Transl Hepatol. 2018 Sep 28;6(3):317-325. doi: 10.14218/JCTH.2018.00006. Epub 2018 Jul 2. J Clin Transl Hepatol. 2018. PMID: 30271745 Free PMC article. Review.
-
Mesenchymal stem cell secretome for regenerative medicine: Where do we stand?J Adv Res. 2025 Apr;70:103-124. doi: 10.1016/j.jare.2024.05.004. Epub 2024 May 9. J Adv Res. 2025. PMID: 38729561 Free PMC article. Review.
-
Mechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview.Cells. 2019 Oct 29;8(11):1339. doi: 10.3390/cells8111339. Cells. 2019. PMID: 31671842 Free PMC article. Review.
-
Recent advances in the therapeutic efficacy of hepatocyte growth factor gene-modified mesenchymal stem cells in multiple disease settings.J Cell Mol Med. 2022 Sep;26(18):4745-4755. doi: 10.1111/jcmm.17497. Epub 2022 Aug 3. J Cell Mol Med. 2022. PMID: 35922965 Free PMC article. Review.
-
The Advances and Biomedical Applications of Imageable Nanomaterials.Front Bioeng Biotechnol. 2022 Jul 5;10:914105. doi: 10.3389/fbioe.2022.914105. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35866027 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical